Eversept Partners LP Has $18.78 Million Stock Holdings in Encompass Health Corporation $EHC

Eversept Partners LP grew its holdings in Encompass Health Corporation (NYSE:EHC) by 81.5% during the 1st quarter, HoldingsChannel reports. The firm owned 194,104 shares of the company’s stock after purchasing an additional 87,178 shares during the quarter. Encompass Health comprises approximately 1.0% of Eversept Partners LP’s holdings, making the stock its 23rd largest position. Eversept Partners LP’s holdings in Encompass Health were worth $18,776,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Encompass Health by 3,059,159.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after acquiring an additional 3,793,358 shares during the last quarter. AlphaCore Capital LLC bought a new stake in shares of Encompass Health during the 4th quarter valued at approximately $4,881,000. SG Americas Securities LLC increased its position in Encompass Health by 1,070.9% during the 4th quarter. SG Americas Securities LLC now owns 88,054 shares of the company’s stock worth $9,346,000 after purchasing an additional 80,534 shares in the last quarter. Sivik Global Healthcare LLC increased its position in Encompass Health by 42.9% during the 4th quarter. Sivik Global Healthcare LLC now owns 50,000 shares of the company’s stock worth $5,307,000 after purchasing an additional 15,000 shares in the last quarter. Finally, Systematic Financial Management LP lifted its stake in Encompass Health by 3.6% in the 4th quarter. Systematic Financial Management LP now owns 440,752 shares of the company’s stock valued at $46,782,000 after purchasing an additional 15,462 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Price Performance

EHC stock opened at $113.77 on Tuesday. The company has a market capitalization of $11.29 billion, a P/E ratio of 18.99, a PEG ratio of 2.46 and a beta of 0.74. The company has a fifty day moving average price of $105.12 and a 200-day moving average price of $103.81. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. Encompass Health Corporation has a 52-week low of $92.77 and a 52-week high of $127.99.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.51 by $0.09. The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. Encompass Health’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, equities analysts expect that Encompass Health Corporation will post 5.96 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.21 per share. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 14.02%.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the company’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $104.56, for a total transaction of $71,309.92. Following the transaction, the executive vice president owned 24,755 shares in the company, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on EHC shares. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Leerink Partners set a $152.00 price objective on Encompass Health in a report on Friday, May 22nd. Weiss Ratings lowered Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, June 26th. TD Cowen assumed coverage on Encompass Health in a report on Thursday, May 28th. They issued a “buy” rating and a $125.00 target price for the company. Finally, Barclays cut their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Encompass Health presently has an average rating of “Moderate Buy” and an average price target of $143.86.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.